Simplified Antibiotic Regimens for Outpatient Treatment of Suspected Sepsis in Neonates and Young Infants in Bangladesh
NCT00844337 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2490
Last updated 2014-09-16
Summary
The primary aim is to establish the non-inferiority of several simplified, home-based antibiotic regimens compared to the standard course of parenteral antibiotics for the empiric treatment of suspected sepsis in Bangladeshi young infants whose parents refuse hospitalization. Three alternative regimens will be compared with a standard (reference) regimen of injectable procaine-benzyl penicillin and gentamicin once daily each for seven days. Alternative regimens are (1) injectable gentamicin once daily and oral amoxicillin twice daily for seven days; (2) injectable penicillin and gentamicin once daily for two days followed by oral amoxicillin twice daily for five days; and (3) injectable gentamicin once daily and oral amoxicillin twice daily for two days followed by oral amoxicillin twice daily for five days.
Hypothesis
The proportion who fails treatment will be 10 percent in the reference group and the alternative treatment groups. An alternative therapy will be considered non-inferior to the standard therapy if the failure rate in the alternative therapy exceeds the failure rate in the injectable therapy by less than 5 absolute percentage points.
Secondary Objectives:
* To identify baseline clinical predictors of treatment failure in severe infections in young infants.
* To determine the proportion of relapse (young infants who were considered cured by day 7 but developed any of the signs of suspected severe infection by day 14).
Conditions
Interventions
- DRUG
-
Gentamicin & Amoxicillin x 7days
Injectable gentamicin once daily and oral amoxicillin twice daily for seven days. The dose for gentamicin is 4 - 5 mg/kg/24 hours. The dose for amoxicillin is 90-115 mg/kg/day.
- DRUG
-
Penicillin & gentamicin x 2 d + Amoxicillin X 5 d
Injectable penicillin and gentamicin once daily for two days followed by oral amoxicillin twice daily for five days. The dose for penicillin is 40,000 - 50,000 U/kg/24 hours, the dose for gentamicin is 4 - 5 mg/kg/24 hours, and the dose for amoxicillin is 90-115 mg/kg/day.
- DRUG
-
Standard reference therapy
Injectable procaine-benzyl penicillin and gentamicin once daily each for seven days. The penicillin dose is 40,000 - 50,000 U/kg/24 hours, and the gentamicin dose is 4 - 5 mg/kg/24 hours.
Sponsors & Collaborators
-
Dhaka Shishu Hospital
collaborator OTHER -
Johns Hopkins Bloomberg School of Public Health
lead OTHER
Principal Investigators
-
Abdullah H Baqui, MBBSMPHDrPH · Johns Hopkins University Bloomberg School of Public Health
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- FACTORIAL
Eligibility
- Max Age
- 59 Days
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-03-31
- Primary Completion
- 2013-09-30
- Completion
- 2013-09-30
Countries
- Bangladesh
Study Locations
More Related Trials
-
Treatment Outcome With Antibiotic Use and Its Resistance Pattern Among Patient With Neonatal Sepsis
NCT05742477 ·Status: UNKNOWN
-
NeoAMR Observational Study in Neonatal Sepsis
NCT03721302 ·Status: COMPLETED
-
Procalcitonin-Guided Decision Making to Shorten Antibiotic Therapy in Suspected Neonatal Early-Onset Sepsis
NCT00926497 ·Status: COMPLETED ·Phase: NA
-
Outcome of Using Hydrocortisone in Early Treatment of Pediatric Septic Shock
NCT07313670 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
PCT Guided Stopping of Antibiotic Therapy in Children With Sepsis
NCT03388944 ·Status: COMPLETED ·Phase: NA
-
Early Identification and Effective Management of Pediatric Sepsis
NCT03996720 ·Status: COMPLETED
-
GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults
NCT00089986 ·Status: COMPLETED ·Phase: PHASE2
-
Safely Reduce Newborn Antibiotic Exposure With the Early-onset Sepsis Calculator
NCT05274776 ·Status: RECRUITING ·Phase: NA
-
Use of Procalcitonin, a Blood Test to Guide Antibiotic Therapy for Sepsis in Adults
NCT05955612 ·Status: COMPLETED ·Phase: PHASE3
-
Balanced Salt Solution VS. Normal Saline Solution in Septic Shock
NCT02336620 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy of Adjunctive Use of Ondansetron in Patients With Sepsis and Septic Shock
NCT05402553 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Clinical Outcome Study of High-dose Meropenem in Sepsis and Septic Shock Patients
NCT03344627 ·Status: COMPLETED ·Phase: NA
-
Prevailing Microorganisms Causing Neonatal Sepsis in Neonatal Intensive Care Unit (Prospective Study)Prevailing Microorganisms Causing Neonatal Sepsis in Neonatal Intensive Care Unit (Prospective Study)
NCT03308526 ·Status: UNKNOWN
-
Efficacy of IgM Rich Immunoglobulin With Antibiotics for Bacterial Sepsis in Very Low Birth Weight Preterm Neonates
NCT03403530 ·Status: COMPLETED ·Phase: PHASE4
-
Neonatal Procalcitonin Intervention Study
NCT00854932 ·Status: UNKNOWN ·Phase: NA
-
Impact of 30 mg/kg Amikacin and 8 mg/kg Gentamicin on Serum Concentrations in Critically Ill Patients With Severe Sepsis
NCT02898961 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Betalactam Antibiotics in Prolonged Infusion Compared to Intermittent in Pediatric Patients With Sepsis
NCT03019965 ·Status: COMPLETED ·Phase: NA
-
Electronic Application of a Severe Sepsis Screening Tool and Management Bundle
NCT01724463 ·Status: UNKNOWN
-
Comparison Between Carbapenems and Noncarbapenem Beta-lactam Antibiotics in Septic Burn Patients
NCT07096310 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Blood Culture Improvement Guidelines and Diagnostic Stewardship for Antibiotic Reduction in Critically Ill Children
NCT03441126 ·Status: COMPLETED
-
Analysis of Differential Proteins and Maternal Influencing Factors of Septic Shock in Neonates
NCT06206590 ·Status: RECRUITING
-
Pharmacokinetics and Pharmacodynamics of High Dose Ceftriaxone in Patients With Sepsis
NCT07245966 ·Status: COMPLETED
-
Study on the Efficacy and Timing of ECMO Therapy in Children With Refractory Septic Shock
NCT03948048 ·Status: RECRUITING
-
Predictive Mini-bolus Fluid Responsiveness in Pediatric Septic Shock
NCT04027699 ·Status: COMPLETED ·Phase: NA
-
Emergency Department Management of Sepsis Patients: A Goal-Oriented Non-Invasive Sepsis Trial
NCT01453270 ·Status: COMPLETED ·Phase: NA